Kymera Therapeutics (KYMR) insider trading in the last 6 months

2 insiders sold $174M. No buys.

Quality Score12Above Average

We do the work for you. Every stock is scored and ranked, every 15 seconds while the market is open. Here it's 15 minutes behind. Pro members see it live.

See all 7 tradesSee it live, free until Thursday morning. No account. No card. Then keep going with a free account.

Form 4 filings, newest first

SellBrian Adams$353KChief Legal Officerat $116.81 on Sep 4, filed Sep 4

SellBrian AdamsChief Legal Officer$353Kat $116.81 on Sep 4, filed Sep 4

SellBrian Adams$251KChief Legal Officerat $117.57 on Sep 4, filed Sep 4

SellBrian AdamsChief Legal Officer$251Kat $117.57 on Sep 4, filed Sep 4

SellBrian Adams$140KChief Legal Officerat $115.55 on Sep 4, filed Sep 4

SellBrian AdamsChief Legal Officer$140Kat $115.55 on Sep 4, filed Sep 4

From SEC Form 4s, the newest filed Sep 4, 2026 · Insiders have 2 business days to file a trade

4 more filings on KYMR in the last 6 months, for Pro members. See them free →

Pro members see every filing on KYMR with what each insider bought or sold and at what price, and can turn on an optional alert when an insider buys.

Who files at Kymera Therapeutics

Brian AdamsChief Legal Officer · 3 sales

Insider trades by person

Tested. Our top-scored stocks returned 2.2x the average stock over the next month. Reconstructed after the fact; recorded live since Sep 9, 2026. How we tested it

Questions about KYMR's insider trades

As of Nov 10, 2026: Kymera Therapeutics (KYMR) has 7 insider filings on record in the last 6 months, the newest filed Sep 4, 2026. Its Quality Score is 12 (Above Average). Scores as of 11:35 PM ET, 15 minutes behind.

Are KYMR insiders buying or selling?

2 insiders sold $174M across 7 filings in the last 6 months. No open-⁠market buys on record. The newest filing: Brian Adams, Chief Legal Officer, sold $353K on Sep 4, 2026.

Who are KYMR's biggest insider sellers?

By the dollars of their sales in the last 6 months: Bvf Partners L P/Il (Director), 4 sales; Brian Adams (Chief Legal Officer), 3 sales.

When did a KYMR insider last buy?

No KYMR insider bought shares on the open market in the last 6 months, as filed on Form 4. The newest filing is a sale by Brian Adams on Sep 4, 2026.

Kymera Therapeutics's page has its Quality Score, its chart, and its earnings. More in Healthcare and Biotech.

Kymera Therapeutics (KYMR) insider trading in the last 6 months

Form 4 filings, newest first

Who files at Kymera Therapeutics

Questions about KYMR's insider trades

Every insider trade, with its stock's score.